Impact of Male Provider Phone Calls to Increase Men's Clinic Linkage After HIVST
Study Details
Study Description
Brief Summary
Evaluate the impact of phone calls from a male counselor in increasing linkage to HIV care and PrEP among male partners of pregnant women attending PMTCT.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Evaluate the impact of phone calls from a male counselor in increasing linkage to HIV care and PrEP among male partners of pregnant women attending PMTCT. Approach: Leveraging the staff and infrastructure of an ongoing study, Kingasa (R01MH113434), we will evaluate the impact of phone calls from a male counselor to encourage male partners to link to HIV care or prevention services after HIV testing. We will provide male counselor follow-up to 100 male partners of pregnant women in the intervention arm of the Kingasa study. We will conduct exit interviews with men and their female partners to assess acceptability and challenges associated with the intervention. We will assess outcomes of ART initiation among HIV-positive men and PrEP by HIV-negative men at 6 months.
Hypothesis: The intervention of a phone call from a male counselor to provide counseling and encourage linkage to HIV care or prevention will be feasible and acceptable. It will result in a higher proportion of men linking to treatment and prevention compared to the standard of care arm of the Kingasa pilot study.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Female SOC/Male SOC arm Women will be provided the standard of care invitation letter for male partners for fast-track visit for HIV testing and laboratory HIV testing at enrollment and every 6 months until 6 months postpartum |
|
Active Comparator: Female intervention/Male SOC arm Women will be provided the standard of care invitation letter for male partners for fast-track visit for HIV testing and POC VL tests for women at enrollment, delivery, and 6 months post-partum |
Diagnostic Test: POC viral load testing
POC viral load testing- women randomized to have POC VL at enrollment, delivery and 6 months post-partum, will have a finger prick to obtain whole blood for the Cepheid Xpert HIV-1 RNA cartridge on the Xpert IV machine with results in 90 minutes. Women who are randomized to POC VL who have VL >200 c/ml will receive additional adherence counseling, following the STREAM protocol, [26] to address the challenges that they are having with ART use. At the delivery visit, infants of women in the POC VL arm will also have viral load testing done.
|
Active Comparator: Female SOC/Male intervention arm Women will be provided an invitation letter for male partners for wellness visits and laboratory-based HIV VL testing for women at enrollment, delivery, and 6 months post-partum |
Other: Wellness visit services for male partners
Wellness visits for men- additional prevention services for men randomized to the intervention arm, including dual syphilis and HIV testing, blood pressure, visual acuity screening, and COVID-19 screening as part of wellness
|
Active Comparator: Female intervention/male intervention arm Women will be provided an invitation letter for male partners for wellness visits and POC viral load testing for women at enrollment, delivery, and 6 months post-partum |
Diagnostic Test: POC viral load testing
POC viral load testing- women randomized to have POC VL at enrollment, delivery and 6 months post-partum, will have a finger prick to obtain whole blood for the Cepheid Xpert HIV-1 RNA cartridge on the Xpert IV machine with results in 90 minutes. Women who are randomized to POC VL who have VL >200 c/ml will receive additional adherence counseling, following the STREAM protocol, [26] to address the challenges that they are having with ART use. At the delivery visit, infants of women in the POC VL arm will also have viral load testing done.
Other: Wellness visit services for male partners
Wellness visits for men- additional prevention services for men randomized to the intervention arm, including dual syphilis and HIV testing, blood pressure, visual acuity screening, and COVID-19 screening as part of wellness
|
Outcome Measures
Primary Outcome Measures
- Male partner linkage [6 months from female partner enrollment]
To assess the proportion of HIV-negative male partners who initiate PrEP and HIV positive men who initiate ART among male partners who test for HIV and are provided male counselor phone follow up or who receive standard of care.
Eligibility Criteria
Criteria
Inclusion Criteria for women:
Age ≥18 or 14-17 years if an emancipated minor (pregnant or have a child), Currently pregnant, Not currently enrolled in an HIV treatment study, Male partner not known to be HIV-positive or has not tested in the past 3 months, Able and willing to provide written informed consent, Able and willing to provide adequate locator information for study retention purposes, Screening negative for any indication of intimate partner violence or social harm
Inclusion Criteria for men:
Female partner enrolled in Kingasa pilot study.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Infectious Disease Institute | Kampala | Uganda |
Sponsors and Collaborators
- University of Washington
- National Institute of Mental Health (NIMH)
Investigators
- Principal Investigator: Monisha Sharma, PhD, ScM, University of Washington
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- STUDY0009286-A
- 1K01MH115789-01A1